Publications found:
1,234
Sort by:
Head and Neck Squamous Cell Carcinoma Market - 2024-2031
US$ 3,400.00
Head and Neck Squamous Cell Carcinoma Market reached US$ 2.2 billion in 2022 and is expected to reach US$ 4.3 billion by 2031, growing with a CAGR of 8.80% during the forecast period 2026-2031. The He...
February 2026
63 pages
Breast Aesthetic Surgery Market - 2024-2031
US$ 3,400.00
Breast Aesthetic Surgery Marketis is growing with a CAGR of 8.50% during the forecast period 2026-2035. The Breast Aesthetic Surgery Market emerges as a key focus in DataM Intelligence latest in-dept...
February 2026
51 pages
Global HER2 ADC Drugs for Cancer Market Growth 2026-2032
US$ 3,660.00
The global HER2 ADC Drugs for Cancer market size is predicted to grow from US$ 7625 million in 2025 to US$ 13720 million in 2032; it is expected to grow at a CAGR of 8.5% from 2026 to 2032. In 2025, g...
January 2026
100 pages
Global HER2 Targeting ADC Drugs Market Growth 2026-2032
US$ 3,660.00
The global HER2 Targeting ADC Drugs market size is predicted to grow from US$ 7811 million in 2025 to US$ 14054 million in 2032; it is expected to grow at a CAGR of 8.5% from 2026 to 2032. In 2025, gl...
January 2026
89 pages
Global Nectin-4 ADC Drugs Market Growth 2026-2032
US$ 3,660.00
The global Nectin-4 ADC Drugs market size is predicted to grow from US$ 1767 million in 2025 to US$ 3240 million in 2032; it is expected to grow at a CAGR of 8.9% from 2026 to 2032. In 2025, global Ne...
January 2026
88 pages
Global Radioligand Therapy Drugs Market Growth 2026-2032
US$ 3,660.00
The global Radioligand Therapy Drugs market size is predicted to grow from US$ 3087 million in 2025 to US$ 5316 million in 2032; it is expected to grow at a CAGR of 8.3% from 2026 to 2032. In 2025, gl...
January 2026
122 pages
Europe Ovarian Cancer Market - 2024-2031
US$ 2,499.00
Europe Ovarian Cancer Market reached in and is expected to reach by , growing with a CAGR of 0.00% during the forecast period 2026-. The Europe Ovarian Cancer Market emerges as a key focus in DataM In...
January 2026
47 pages
Hurthle Cell Carcinoma Market - 2024-2031
US$ 3,400.00
Hurthle Cell Carcinoma Marketis is growing with a CAGR of 6.00% during the forecast period 2026-2035. The Hurthle Cell Carcinoma Market emerges as a key focus in DataM Intelligence latest in-depth ana...
January 2026
48 pages
Global Ubenimex Capsules Market Growth 2026-2032
US$ 3,660.00
The global Ubenimex Capsules market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Ubenimex (also known as bestatin)...
January 2026
77 pages
Global Aromatase Inhibitors?AI? Market Growth 2026-2032
US$ 3,660.00
The global Aromatase Inhibitors?AI? market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Aromatase inhibitors are a...
January 2026
161 pages
Global Tamoxifen Drugs Market Growth 2026-2032
US$ 3,660.00
The global Tamoxifen Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Tamoxifen is a selective estrogen r...
January 2026
108 pages
Cancer Immunotherapy Market Forecasts to 2032 - Global Analysis By Type (Immune Checkpoint Inhibitors, Monoclonal Antibodies, Cancer Vaccines, Adoptive Cell Transfer Therapy, Cytokines and Oncolytic Virus Therapy), Treatment Setting, Technology, Application, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Cancer Immunotherapy Market is accounted for $140.63 billion in 2025 and is expected to reach $250.55 billion by 2032 growing at a CAGR of 8.6% during the fore...
January 2026
200 pages
Angiosarcoma Treatment Market - 2024-2031
US$ 3,400.00
Angiosarcoma Treatment Market reached USD 253.1 million in 2022 and is expected to reach USD 412.3 million by 2031, growing with a CAGR of 6.40% during the forecast period 2026-2031. The Angiosarcoma...
January 2026
48 pages
Germ Cell Tumor Treatment Market - 2024-2031
US$ 3,400.00
The Germ Cell Tumor Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to delive...
January 2026
51 pages
Lung Cancer Therapeutics Market - 2025-2033
US$ 3,400.00
Lung Cancer Therapeutics Market reached US$ 24.00 Billion in 2023 and is expected to reach US$ 55.09 Billion by 2033, growing with a CAGR of 8.80% during the forecast period 2026-2033. The Lung Cancer...
January 2026
50 pages
Metastatic Colorectal Cancer Market - 2024-2031
US$ 3,400.00
Metastatic Colorectal Cancer Market reached US$ 3.4 billion in 2022 and is expected to reach US$ 4.8 billion by 2031, growing with a CAGR of 4.60% during the forecast period 2026-2031. The Metastatic...
January 2026
54 pages
Penile Cancer Treatment Market - 2024-2031
US$ 3,400.00
Penile Cancer Treatment Marketis is growing with a CAGR of 5.60% during the forecast period 2026-2035. The Penile Cancer Treatment Market emerges as a key focus in DataM Intelligence latest in-depth a...
January 2026
49 pages
Breast Cancer Therapeutics Market - Global Industry Size, Share, Trends, Opportunity and Forecast, Segmented By Therapy (Chemotherapy (Anthracyclines, Taxanes, Antimetabolites, Others), Hormone Therapy, Immunotherapy, Targeted Therapy, Others), By Hormone Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, Others), By Targeted Therapy (Monoclonal Antibodies, Tyrosine Kinase Inhibitor, Herceptin, Others), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Breast Cancer Therapeutics Market is projected to experience significant growth, rising from a valuation of USD 41.91 billion in 2025 to USD 74.29 billion by 2031, reflecting a compound ann...
January 2026
180 pages
Soft Tissue Sarcoma Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type (Targeted Therapy, Chemotherapy, Anti-Angiogenesis Drugs, Radiation Therapy, Others), By End User (Hospitals, Homecare, Specialty Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Soft Tissue Sarcoma Market is projected to expand from a valuation of USD 1.71 Billion in 2025 to USD 2.78 Billion by 2031, reflecting a Compound Annual Growth Rate (CAGR) of 8.44%. Soft ti...
January 2026
180 pages
Cancer Monoclonal Antibodies Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Type of Monoclonal Antibody (Murine Antibodies, Chimeric Antibodies, Humanized Antibodies), By Monoclonal Antibody Therapies (Bevacizumab (Avastin), Rituximab (Rituxan), Trastuzumab (Herceptin), Cetuximab (Erbitux), Panitumumab (Vectibix), Other), By Application (Breast Cancer, Blood Cancer, Liver Cancer, Brain Cancer, Colorectal Cancer, Other), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Cancer Monoclonal Antibodies Market is projected to expand from USD 99.66 Billion in 2025 to USD 244.95 Billion by 2031, reflecting a compound annual growth rate of 16.17%. These laboratory...
January 2026
181 pages
Biliary Tract Cancers Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Cancer Type (Intrahepatic Cholangiocarcinoma (ICC), Extrahepatic Cholangiocarcinoma, Gallbladder Cancer), By End-User (Hospitals, Specialty Cancer Centres, Ambulatory Surgical Centres, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Biliary Tract Cancers Market is projected to expand from USD 675.69 Million in 2025 to USD 892.63 Million by 2031, achieving a compound annual growth rate (CAGR) of 4.75%. This sector compr...
January 2026
180 pages
Cancer Biological Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Cancer Growth Blockers, Monoclonal Antibodies, Vaccines), By Distribution Channel (Hospitals, Retail & Mail Order Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Cancer Biological Therapy Market is projected to expand from USD 116.12 Billion in 2025 to USD 182.03 Billion by 2031, achieving a compound annual growth rate of 7.78%. Cancer biological th...
January 2026
180 pages
Chemotherapy-Induced Anemia Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type (Mild Anemia, Moderate Anemia, Severe Anemia), By Treatment Type (RBC Transfusions, Erythropoiesis-stimulating agents (ESAs), Iron Supplementation), By Drug Type (Epogen Injection, Procrit Injection, Androxy Oral, Aranesp injection, Epoetin Alfa Injection, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Chemotherapy-Induced Anemia Market is projected to expand from USD 2.86 Billion in 2025 to USD 4.33 Billion by 2031, reflecting a compound annual growth rate of 7.16%. Therapeutics within t...
January 2026
185 pages
Malignant Mesothelioma Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (Pemetrexed, Cisplatin, Carboplatin, Gemcitabine, Vinorelbine, Others), By Route of Administration (Oral, Parenteral), By End User (Hospitals, Cancer Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Malignant Mesothelioma Therapeutics Market is projected to expand from USD 260.62 Million in 2025 to USD 382.21 Million by 2031, registering a compound annual growth rate of 6.59%. This mar...
January 2026
185 pages
Non-Small Cell Lung Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Adenocarcinoma, Squamous Cell Carcinoma, Large Cell Carcinoma), By Treatment (Chemotherapy, Immunotherapy, Radiation Therapy, Surgery, Targeted Therapy Drugs), By Drug Class (Angiogenesis Inhibitor, Epidermal Growth Factor Receptor Blocker, Kinase Inhibitor, Microtubule Stabilizer, Folate Antimetabolites, PD-1/ PD-L1 Inhibitor), By End-User (Hospitals & Clinics, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Non-Small Cell Lung Cancer Market is projected to expand from USD 20.02 Billion in 2025 to USD 36.86 Billion by 2031, reflecting a CAGR of 10.71%. This market encompasses the development an...
January 2026
186 pages
Pituitary Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Cancer Type (Pituitary Adenoma (Benign Tumor), Pituitary Carcinoma (Malignant Tumor)), By Hormone Type (Prolactinoma, Growth Hormone-Secreting Tumor (Acromegaly), Adrenocorticotropic Hormone-Secreting Tumor (Cushings Disease), Thyroid-Stimulating Hormone-Secreting Tumor (TSHoma), Gonadotropin-Secreting Tumor), By Treatment Type (Surgery, Radiation Therapy, Medications, Targeted Therapy, Chemotherapy), By End User (Hospitals, Specialty Clinics, Cancer Treatment Centers, Research Institutes), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Pituitary Cancer Market is projected to expand significantly, rising from USD 476.55 Million in 2025 to USD 843.32 Million by 2031, reflecting a compound annual growth rate of 9.98%. This s...
January 2026
185 pages
Wilms Tumor Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Favorable Histology, Anaplastic Histology), By Treatment (Surgery, Chemotherapy, Radiation Therapy, Others), By End User (Hospitals, Cancer Research Centers, Academic and Research Institutes, Others) By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Wilms Tumor Treatment Market is projected to expand from USD 1.64 Billion in 2025 to USD 2.17 Billion by 2031, growing at a CAGR of 4.78%. This market encompasses specialized medical interv...
January 2026
180 pages
Laryngeal Cancer Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Biologics, Small Molecules), By End-User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Laryngeal Cancer Therapeutics Market is projected to expand from USD 4.09 Billion in 2025 to USD 5.36 Billion by 2031, registering a compound annual growth rate of 4.61%. This sector compri...
January 2026
180 pages
mTOR Inhibitors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Rapamune, Afinitor, Torisel, Zortress, Other), By Indication (Oncology, Immunosuppressant, Organ Transplantation, Other), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global mTOR Inhibitors Market is projected to expand from a valuation of USD 4.56 Billion in 2025 to USD 6.46 Billion by 2031, exhibiting a Compound Annual Growth Rate (CAGR) of 5.98%. These pharm...
January 2026
180 pages
Myelodysplastic Syndrome (MDS) Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type (Stem Cell Transplant, Immune Treatments, Chemotherapy, Immunomodulatory Drugs, Anti-anemics, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Myelodysplastic Syndrome (MDS) Treatment Market is projected to expand from USD 3.04 Billion in 2025 to USD 4.33 Billion by 2031, reflecting a compound annual growth rate of 6.07%. Treatmen...
January 2026
180 pages
